Oruka Therapeutics (ORKA) Assets Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Oruka Therapeutics | 3.04 Bn | 2.65 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 128.91% |
| Dec 31, 2025 | 124.67% |
| Sep 30, 2025 | 124.57% |
| Jun 30, 2025 | 95.14% |
| Mar 31, 2025 | 94.80% |
| Dec 31, 2024 | 93.19% |
| Sep 30, 2024 | 90.19% |
| Jun 30, 2024 | -19.69% |
| Mar 31, 2024 | -19.04% |
| Dec 31, 2023 | -9.11% |
| Sep 30, 2023 | -8.99% |
| Jun 30, 2023 | 52.28% |
| Mar 31, 2023 | 77.97% |
| Dec 31, 2022 | 71.54% |
| Sep 30, 2022 | 65.34% |
| Jun 30, 2022 | 66.68% |
| Mar 31, 2022 | 80.98% |
| Dec 31, 2021 | 100.39% |
| Sep 30, 2021 | 92.45% |
| Jun 30, 2021 | 86.53% |
| Mar 31, 2021 | 75.55% |
| Dec 31, 2020 | 59.77% |
| Sep 30, 2020 | 45.37% |
| Jun 30, 2020 | -12.38% |
| Mar 31, 2020 | -28.71% |
| Dec 31, 2019 | -29.76% |
| Sep 30, 2019 | -29.74% |
| Jun 30, 2019 | -31.72% |
| Mar 31, 2019 | -38.46% |
| Dec 31, 2018 | -44.34% |
| Sep 30, 2018 | -41.60% |
| Jun 30, 2018 | -39.35% |
| Mar 31, 2018 | -1.20% |
| Dec 31, 2017 | -8.48% |
| Sep 30, 2017 | -2.11% |
| Jun 30, 2017 | -5.57% |
| Mar 31, 2017 | -3.14% |
| Dec 31, 2016 | 12.97% |
| Sep 30, 2016 | 14.43% |
| Jun 30, 2016 | 16.23% |
| Mar 31, 2016 | 107.41% |
| Dec 31, 2015 | 130.96% |
| Sep 30, 2015 | 130.50% |
| Jun 30, 2015 | 127.81% |
| Mar 31, 2015 | 38.81% |
| Dec 31, 2014 | 35.38% |
| Sep 30, 2014 | 40.54% |
| Jun 30, 2014 | 33.77% |
| Dec 31, 2013 | 27.95% |